Potential test systems for chemotherapeutic agents against prostatic cancer.
作者信息
Sandberg A A
出版信息
Vitam Horm. 1975;33:155-88. doi: 10.1016/s0083-6729(08)60954-1.
PMID:820067
Abstract
摘要
相似文献
1
Potential test systems for chemotherapeutic agents against prostatic cancer.
Vitam Horm. 1975;33:155-88. doi: 10.1016/s0083-6729(08)60954-1.
2
Potential test systems for drugs against prostatic cancer.
Cancer Chemother Rep. 1975 Jan-Feb;59(1):175-84.
3
5alpha-Reductase as a target enzyme for anti-prostatic drugs in organ culture.
Oncology. 1977;34(3):123-8. doi: 10.1159/000225204.
4
Some new approaches to potential test systems for drugs against prostatic cancer.
Cancer Treat Rep. 1977 Mar-Apr;61(2):289-95.
5
A comparative study of binding, metabolism and endogenous levels of androgens in normal, hyperplastic and carcinomatous human prostate.正常、增生及癌性人前列腺中雄激素的结合、代谢及内源性水平的比较研究。
J Steroid Biochem. 1979 Jul;11(1B):615-24. doi: 10.1016/0022-4731(79)90090-6.
6
7
Studies on the antiprostatic action of estracyt, a nitrogen mustard of estradiol.雌氮芥（一种雌二醇氮芥）抗前列腺作用的研究。
Cancer Res. 1974 May;34(5):1031-7.
8
Prostatic effects of a nonsteroidal antiandrogen.
Invest Urol. 1975 Jan;12(4):275-84.
9
Comparison and significance of respiration and glycolysis of prostatic tissue from various species.
J Med Primatol. 1975;4(4):245-51. doi: 10.1159/000459860.
10
Distribution of simultaneously injected androgens and estrogens in animal tissues.
Endocrinology. 1972 May;90(5):1245-51. doi: 10.1210/endo-90-5-1245.
引用本文的文献
1
Steroid hormone receptors in the regulation of differentiation. A review.类固醇激素受体在分化调控中的作用。综述。
Am J Pathol. 1977 Mar;86(3):705-44.
Zotero 插件